BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24104749)

  • 1. The regulatory landscape for actively personalized cancer immunotherapies.
    Britten CM; Singh-Jasuja H; Flamion B; Hoos A; Huber C; Kallen KJ; Khleif SN; Kreiter S; Nielsen M; Rammensee HG; Sahin U; Hinz T; Kalinke U
    Nat Biotechnol; 2013 Oct; 31(10):880-2. PubMed ID: 24104749
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Cancer Vaccines Advance in the Clinic.
    Schmidt C
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29095978
    [No Abstract]   [Full Text] [Related]  

  • 4. Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.
    Bendjama K; Quemeneur E
    Hum Vaccin Immunother; 2017 Sep; 13(9):1997-2003. PubMed ID: 28846477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine.
    Parums DV
    Med Sci Monit; 2021 May; 27():e933088. PubMed ID: 33994538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoepitope Vaccines Next Immunotherapy Frontier.
    Cancer Discov; 2016 Feb; 6(2):112. PubMed ID: 26712929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
    Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
    Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer neoantigen: Boosting immunotherapy.
    Xu P; Luo H; Kong Y; Lai WF; Cui L; Zhu X
    Biomed Pharmacother; 2020 Nov; 131():110640. PubMed ID: 32836075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How personalized cancer vaccines could keep tumours from coming back.
    Dolgin E
    Nature; 2024 Jun; 630(8016):290-292. PubMed ID: 38862759
    [No Abstract]   [Full Text] [Related]  

  • 11. [Personalized peptide vaccine for cancer treatment; now and its future].
    Waki K; Yamada A
    Nihon Rinsho; 2017 Feb; 75(2):251-256. PubMed ID: 30562860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does a cancer vaccine work?
    Drew L
    Nature; 2024 Mar; 627(8005):S34-S35. PubMed ID: 38538946
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in personalized cancer immunotherapy.
    Kakimi K; Karasaki T; Matsushita H; Sugie T
    Breast Cancer; 2017 Jan; 24(1):16-24. PubMed ID: 27000871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Immuno-Oncology.
    Jain KK
    Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics.
    Advani D; Sharma S; Kumari S; Ambasta RK; Kumar P
    Anticancer Agents Med Chem; 2022; 22(3):433-468. PubMed ID: 33687887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
    Pan RY; Chung WH; Chu MT; Chen SJ; Chen HC; Zheng L; Hung SI
    J Immunol Res; 2018; 2018():4325874. PubMed ID: 30662919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Researchers push for personalized tumour vaccines.
    Ledford H
    Nature; 2016 Apr; 532(7600):425. PubMed ID: 27121818
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of immune repertoire sequencing in cancer immunotherapy.
    Zhuang Y; Zhang C; Wu Q; Zhang J; Ye Z; Qian Q
    Int Immunopharmacol; 2019 Sep; 74():105688. PubMed ID: 31276974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.